Last reviewed · How we verify
NCT05702450
Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310
Phase 1 trial testing CM310 in Healthy in 240 participants. Completed in 26 July 2023.
26 July 2023
Quick facts
| Lead sponsor | Keymed Biosciences Co.Ltd |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 22 March 2023 |
| Primary completion | 26 July 2023 |
| Estimated completion | 26 July 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- CM310 — full drug profile →
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Keymed Biosciences Co.Ltd — full company profile →
Who can join
Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-center, randomized, open study to evaluate the pharmacokinetics, safety and immunogenicity CM310 in healthy subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05702450
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CM310
Trials testing the same drug.
- NCT06547333 — A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2, PHASE3 · not yet recruiting
- NCT06495229 — Study of CM310 in Adolescent Subjects With Atopic Dermatis · Phase 3 · active not recruiting
- NCT06171048 — Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects · Phase 1 · unknown
- NCT06171074 — Study of CM310 in Subjects With Seasonal Allergic Rhinitis · Phase 2 · unknown
- NCT06116565 — A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis · Phase 2 · unknown
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Keymed Biosciences Co.Ltd trials
Trials by the same sponsor.
- NCT07519577 — A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2） · Phase 2 · not yet recruiting
- NCT07166211 — Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) · Phase 2 · recruiting
- NCT07175493 — A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia · Phase 1, PHASE2 · recruiting
- NCT07011524 — Study of CM512 Injection in Subjects With Moderate-to-severe Asthma · Phase 2 · recruiting
- NCT07039578 — Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05702450 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Keymed Biosciences Co.Ltd
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05702450.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing